Form D · Private Equity Fund

NEXTBio Innovation SPV I LLC

Menlo Park, CA · CIK 0002079662

Offering snapshot reported Aug 1, 2025 · SEC filing

Reported sold
Yet to sell
Indefinite offering
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 1, 2025InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-553467

Source: Form D, filed Aug 1, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

NEXTBIO EVERGREEN LLC

Investment adviser: NEXTBIO CAPITAL MANAGEMENT LP

Gross asset value
$90.8M
Beneficial owners
2
ADV minimum commitment
$10M

Reported in Form ADV on Jul 7, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SS&C TECHNOLOGIES, INC. NEW YORK, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LLP SAN FRANCISCO, California, United States
Custodian GOLDMAN SACHS & CO. LLC NEW YORK, New York, United States Related to adviser: No
Custodian JEFFERIES LLC NEW YORK, New York, United States Related to adviser: No
Prime broker GOLDMAN SACHS & CO. LLC NEW YORK, New York, United States
Prime broker JEFFERIES LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG LLP
PCAOB 185

GOLDMAN SACHS & CO. LLC
SEC 8-129

JEFFERIES LLC
SEC 8-15074

GOLDMAN SACHS & CO. LLC
CRD 361 · SEC 8-129

JEFFERIES LLC
CRD 2347 · SEC 8-15074

Filing source

Form ADV 2118124 · Jul 7, 2026 · Schedule D 7.B.(1), fund 805-8061740452

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Next Bio Capital Innovation Spv I Gp Llc Executive, Promoter
Next Bio Capital Management Lp Executive, Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
3000 Sand Hill Road Suite 3 210
Menlo Park, CA, 94025